Neurocrine Biosciences, Inc. (NBIX)
NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 135.29 |
| 開市 | 135.82 |
| 買盤 | 0.00 x 0 |
| 賣出價 | 0.00 x 0 |
| 今日波幅 | 130.67 - 136.45 |
| 52 週波幅 | 93.02 - 148.37 |
| 成交量 | |
| 平均成交量 | 796,866 |
| 市值 | 13.169B |
| Beta 值 (5 年，每月) | 0.36 |
| 市盈率 (最近 12 個月) | 35.56 |
| 每股盈利 (最近 12 個月) | 3.68 |
| 業績公佈日 | 2024年7月30日 - 2024年8月05日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 1995年12月29日 |
| 1 年預測目標價 | 159.46 |
Investor's Business DailyNeurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
Neurocrine Biosciences continues to put up really healthy numbers, with an ostensible 335% profit hike on a powerful reversal last quarter. On Friday, Neurocrine Biosciences stock got a Relative Strength (RS) Rating upgrade from 77 to 82. The upgraded 82 RS Rating means Neurocrine Biosciences stock is among the top 18% overall for price performance over the past year.
Investor's Business DailyHow Neurocrine Is Stacking Up Wins In 2024 — And Outperforming Peers
Neurocrine Biosciences is making good on its promise to diversify from Ingrezza. Meanwhile, the biotech stock is angling for a record.
Investor's Business DailyNvidia Leads Five Stocks Near Buy Points As Market Rally Picks Up Steam
Nvidia stock along with four other leading stocks are in or near buy areas as the market rally appears to be picking up steam.
